Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Anticancer Agent LENVIMA® Approved for Additional Indication of Unresectable Hepatocellular Carcinoma in Japan, First Approval Worldwide for LENVIMA for HCC

biospaceMarch 26, 2018

Tag: Lenvima , carcinoma

PharmaSources Customer Service